Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nikos Constantinou"'
Autor:
Georgia Levidou, Maria K. Angelopoulou, Maria Dimou, Sotirios G. Papageorgiou, John Dervenoulas, Andreas Katsigiannis, Panagiota Economopoulou, Panayiotis Panayiotidis, George Georgiou, Christina Kalpadakis, Photis Beris, Meletios-Athanassios Dimopoulos, Panagiotis Tsirigotis, John Meletis, Ioannis Kotsianidis, Panayiotis Diamantopoulos, Marie-Christine Kyrtsonis, Gerassimos A. Pangalis, Anna Efthimiou, Theodoros P. Vassilakopoulos, Vassiliki Pappa, Christina Economopoulou, Penelope Korkolopoulou, Nikos Constantinou
Publikováno v:
Hematological Oncology. 31:10-17
Central nervous system (CNS) involvement in patients with primary mediastinal large B-cell (PMLBCL) lymphoma is a rare event, occurring in approximately 6% of patients, on the basis of the review of the literature prior to induction of Rituximab. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6dc2bdc7c01e993fda6fcd573470db6
https://doi.org/10.1002/hon.2012
https://doi.org/10.1002/hon.2012
Autor:
Marina P. Siakantaris, Stella I. Kokoris, Theodoros P. Vassilakopoulos, Evangelos Terpos, John Meletis, Nikos Constantinou, Photis Beris, Christos Poziopoulos, Gerassimos A. Pangalis, John Dervenoulas, Andreas Katsigiannis, Meletios A. Dimopoulos, Effimia Vrakidou, Paraskevi Roussou, Christina Kalpadakis, Evagelia M. Dimitriadou, Zacharoula Galani, Sotirios G. Papageorgiou, Marie-Christine Kyrtsonis, Maria N. Dimopoulou, Panayiotis Panayiotidis, Sotirios Sachanas, Maria K. Angelopoulou, Alexandra Zorbala, Panagiotis Repoussis
Publikováno v:
The Oncologist. 17:239-249
Learning Objectives After completing this course, the reader will be able to: Describe the effect of the addition of rituximab to standard CHOP chemotherapy on the outcome of patients with primary mediastinal large B-cell lymphoma.Explain potential c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc3568e7fac84ed7ea0733dddb30748c
https://doi.org/10.1634/theoncologist.2011-0275
https://doi.org/10.1634/theoncologist.2011-0275
Autor:
Robert C. Miller, Ron Epelbaum, Angela M. Mamusa, Nuran Bese, Nikos Constantinou, Anna Lucas Calduch, Anna Kowalczyk, Mahmut Ozsahin, Yavuz Anacak, Serra Kamer, Sidney P. Kadish, Damien C. Weber, Philip Poortmans, Yexiong Li
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 82:315-320
Involvement of salivary glands with mucosa-associated lymphoid tissue (MALT) lymphoma is rare. This retrospective study was performed to assess the clinical profile, treatment outcome, and prognostic factors of MALT lymphoma of the salivary glands.Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11e4f61efd97e04a716aed21b57988b1
https://doi.org/10.1016/j.ijrobp.2010.09.046
https://doi.org/10.1016/j.ijrobp.2010.09.046
Autor:
Dimitrios Kapetanos, Konstantinos Laschos, Nikos Constantinou, Evgenia Verrou, Eirini Katodritou, Evangelos Terpos, Christina Hadjiaggelidou, Konstantinos Zervas, Vassiliki Gastari, Loukas Kontovinis
Publikováno v:
American Journal of Hematology. 83:697-701
The impact of erythropoiesis-stimulating agent (ESA) on cancer patients' survival has recently become a matter of extensive discussion. Studies in solid tumors demonstrated that ESA adversely affects survival. This issue has not been sufficiently stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25aeba582087e2df8e996c2ffefe0066
https://doi.org/10.1002/ajh.21239
https://doi.org/10.1002/ajh.21239
Autor:
John Christakis, George Gavrielidis, Grigoris T. Gerotziafas, Costas Zervas, Evdoxia Hatjiharissi, Mary Papaioannou, Nikos Constantinou, Anna Lazaridou, Aggelos Tokmaktsis, Meyer Michel Samama
Publikováno v:
American Journal of Hematology. 69:219-222
We report two patients with severe thrombocytopenia and life-threatening bleeding that were successfully managed with recombinant activated factor VII (rFVIIa). The first was a 75-year-old male with Waldenström's macroglobulinemia. During a therapeu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fedd5ae2bdf326e823f7329c98ea7d54
https://doi.org/10.1002/ajh.10056
https://doi.org/10.1002/ajh.10056
Autor:
Sotirios G, Papageorgiou, Panayiotis, Diamantopoulos, Georgia, Levidou, Maria K, Angelopoulou, Panagiota, Economopoulou, Anna, Efthimiou, Nikos, Constantinou, Andreas, Katsigiannis, Penelope, Korkolopoulou, Vassiliki, Pappa, Christina, Economopoulou, George, Georgiou, Maria, Dimou, Panagiotis, Tsirigotis, Marie-Christine, Kyrtsonis, Ioannis, Kotsianidis, Christina, Kalpadakis, Meletios-Athanassios, Dimopoulos, Photis, Beris, John, Meletis, Gerassimos A, Pangalis, John, Dervenoulas, Panayiotis, Panayiotidis, Theodoros P, Vassilakopoulos
Publikováno v:
Hematological oncology. 31(1)
Central nervous system (CNS) involvement in patients with primary mediastinal large B-cell (PMLBCL) lymphoma is a rare event, occurring in approximately 6% of patients, on the basis of the review of the literature prior to induction of Rituximab. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ab4fcbe1854945c6f16d1241d6e4de8c
https://pubmed.ncbi.nlm.nih.gov/22610484
https://pubmed.ncbi.nlm.nih.gov/22610484
Autor:
Panayiotis Panayiotidis, Themistoklis Karmiris, Konstantinos Konstantopoulos, Eleni Variamis, Theodoros P. Vassilakopoulos, Paraskevi Roussou, Nora-Athina Viniou, Evangelia M. Dimitriadou, Christos Kittas, Maria K. Angelopoulou, Panayiotis Repoussis, Penelope Korkolopoulou, Styliani I. Kokoris, Maria N. Dimopoulou, Nikos Constantinou, Gerassimos A. Pangalis, Ipatia Doussis-Anagnostopoulou, Efstratios Patsouris, Marie-Christine Kyrtsonis, Vassiliki A. Boussiotis, Athina Androulaki, Marina P. Siakantaris
Publikováno v:
Blood. 105(5)
We developed a clinical prediction rule for bone marrow involvement (BMI) in Hodgkin lymphoma based on 826 patients and validated it in 654 additional patients. Independent prognostic factors for BMI were x 1 , B symptoms; x 2 , stage III/IV prior to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a4eec7c6288641884c8edbc1208b8a7
https://pubmed.ncbi.nlm.nih.gov/15536150
https://pubmed.ncbi.nlm.nih.gov/15536150
Rituximab-CHOP (R-CHOP) and Radiotherapy (RT) for Primary Mediastinal Large B-Cell Lymphoma (PMLBCL)
Autor:
Elias Kyriakou, Evangelia M. Dimitriadou, Christina Kalpadaki, Nikos Constantinou, Effimia Vrakidou, Christos Poziopoulos, Nora-Athina Viniou, Gerassimos A. Pangalis, Maria N. Dimopoulou, Penelope Korkolopoulou, Panayiotis Repoussis, Panayiotis Panayiotidis, Sotirios Sachanas, Maria K. Angelopoulou, Marie-Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Andreas Katsigiannis, Stiliani I. Kokoris, Paraskevi Roussou, Marina P. Siakantaris, Evridiki Michali, Zacharoula Galani, Flora N. Kontopidou
Publikováno v:
Blood. 108:2745-2745
Background: MACOP-B or even chemotherapy (CT) with consolidation high dose therapy with autologous stem cell support (HDT-ASCT) have been considered superior to CHOP in PMLBCL. However, in the absence of randomized trials, there is no established opt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::620e78da358932183b8c83450be404b5
https://doi.org/10.1182/blood.v108.11.2745.2745
https://doi.org/10.1182/blood.v108.11.2745.2745